Mechanisms of hemoglobin cycling in anemia patients treated with erythropoiesis-stimulating agents

Patients with renal anemia are frequently treated with erythropoiesis-stimulating agents (ESAs), which are dynamically dosed in order to stabilize blood hemoglobin levels within a specified target range. During typical ESA treatments, a fraction of patients experience hemoglobin ‘cycling’ periods du...

Descripción completa

Detalles Bibliográficos
Autores principales: Jörg, David J., Fuertinger, Doris H., Kotanko, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873166/
https://www.ncbi.nlm.nih.gov/pubmed/36693034
http://dx.doi.org/10.1371/journal.pcbi.1010850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873166/
https://www.ncbi.nlm.nih.gov/pubmed/36693034
http://dx.doi.org/10.1371/journal.pcbi.1010850

Ejemplares similares